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Summary 
The common y chain (yc) of the IL-2, 11-4, IL-7, IL-g, 
and IL-15 receptors is defective in humans with XSCID. 
Mice lacking ys expression had hypoplastic thymuses; 
the thymocytes responded to ye-independent mito- 
gens, but not y&ependent stimuli. Splenic T cells 
were diminished at 3 weeks of age, but CD4+ T cells 
markedly increased by 4 weeks. B cells were greatly 
diminished, in contrast with the situation in XSCID. NK 
cells, y6 intestinal intraepithelial lymphocytes, den- 
dritic epidermal T cells, peripheral lymph nodes, and 
gut-associated lymphoid tissue were absent. These 
findings underscore the importance of T= In lymphoid 
development. Moreover, differences in humans and 
mice lacking Te expression indicate species-specific 
differences in the roles of yc-dependent cytokines or 
in the existence of redundant pathways. These mice 
provide an impotiant model for studying the patho- 
physiology of and gene therapy for human XSCID. 
Turrent address: Anatomy Department, Monash University, Welling- 
ton Road, Clayton, 3166, Victoria, Australia 
Introduction 
X-linked severe combined immunodeficiency (XSCID) in 
humans is characterized by profoundly diminished cell- 
mediated and humoral immunity, with death typically oc- 
curring in the first year of life in the absence of successful 
bone marrow transplantation (Conley, 1992; Leonard et 
al., 1994). T cells and natural killer (NK) cells are absent 
or profoundly reduced in numbers and B cells, while pres- 
ent in normal or increased numbers, are nonfunctional, 
ostensibly due to a combination of lack of T cell help as 
well as an intrinsic B cell defect. XSCID results from muta- 
tions in the gene encoding the common y chain, “IC (No- 
guchi et al., 1993c), which is an essential signaling compo- 
nent of the receptors for interleukin-2 (IL-2) (Takeshita et 
al., 1992) IL-4 (Kondo et al., 1993; Russell et al., 1993) 
IL-7 (Noguchi et al., 1993b; Kondo et al., 1994), IL-9 (Rus- 
sell et al., 1994), and IL-15 (Giri et al., 1994). The clinical 
manifestations in XSCID, therefore, result from the con- 
comitant inactivation of at least five different cytokine sys- 
tems. yc associates with and mediates the activation of 
the Janus family tyrosine kinase, Jak3 (Boussiotis et al., 
1994; Russell et al., 1994; Miyazaki et al., 1994). Thus, 
at least some of the signaling and developmental defects 
found in XSCID are likely to result from a failure to activate 
Jak3. 
To advance our understanding of the developmental 
role of yc as well as to create a murine model for XSCID 
gene therapy, we have generated mice in which the yc 
gene was disrupted by homologous recombination. 
Whereas heterozygous (rc+‘-) female mice exhibited nor- 
mal immune function, males lacking yc expression (~~-9 
had severe cellular abnormalities characterized by an ab- 
sence of NK cells and greatly diminished B and T cells, 
including a complete absence of Thy1 + $5 dendritic epider- 
mal T cells (DETC) and intraepithelial lymphocytes (IEL). 
However, it was also striking that T cells were present 
and could proliferate in response to mitogenic stimuli. The 
implications of these findings are discussed. 
Results 
Characterization of the Murine ys Gene, Preparation 
of a Targeting Construct, and Creation 
of yc-Deficient Mice 
Like human yc, the murine Ye gene is located on the X 
chromosome (Cao et al., 1993). The organization of the 
gene (Figure 1 A), including its restriction map, sequence 
(5267 bp spanning all exons and introns, deposited in Gen- 
Bank), and exon-intron boundaries were determined. 
Both human (Noguchi et al., 1993a) and murine (Figure 
1A) 7/c genes have eight exons and similar exon-intron 
boundaries. This information was utilized to prepare a 
sequence replacement targeting construct, denoted 
pPNTycl .3/2.0 (Figure 1 A), designed to delete by homolo- 
gous recombination part of exon 3 and all of exons 4-8, 
thereby resulting in the loss of much of the Tc extracellular 
domain as well as the entire transmembrane and cyto- 
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Figure 1. inactivation of the ye Gene by Homol- 
ogous Recombination 
(A) At the top, the exon-intron organization of 
the murine yc gene is shown, with exon and 
intron sequences in upper and lower case let- 
ters, respectively. Exon and intron sizes are 
given, a8 well as the amino acids interrupted 
by each intron. The consensus splice donor 
and acceptor sequences are boxed. Below are 
schematics of the normal murine yc gene (with 
the positions of the eight exons indicated by 
closed boxes, partial restriction map, and the 
15 kb Notl and 7 kb Hlndlll genomlc fragments), 
the targeting vector, pPNTyel .3/2.0 (showing 
the positions of the neo and hsv-f/r genes and 
the regionsof identity with the T.gene), and the 
predicted homologous recombinant (including 
the posftion of the 2.5 kb Hindiii fragment that 
is detected upon hybridization with probe A). 
(6) identification of an ES cell clone in which 
they. gene has been targeted by homologous 
recombination. DNA was digested to comple- 
tion with Hindiii and then Southern blotted us- 
ing probe A (see [A]). Shown are six ES clones 
with the normal 7 kb germiine configuration 
(lanes 1.2, and 4-7). and one in which homoio- 
gous recombination occurred to yield a 2.5 kb 
band (lane 3). 
(C) Southern blotting of Hindlll-digested DNA 
from a ye” male (lane l), heterozygous female 
(iane2), and wild-type male (lane 3) using probe 
A. As expected, a 7 kb band was seen in lanes 
2 and 3, and a 2.5 kb band was seen in lanes 
1 and 2. 
(D) Nested PCR was used to identify rapidly 
the homoiogously recombined +rreo gene 
construct that was present in 79 males (lanes 
1, 2, 6, 13, and 16-16) and heterozygous (+I-) 
females (lanes 5,9, 11,12) but not in wild-type 
males (lanes 7, 14, 15) or females (lanes 3, 4, 
6, 10, 19). The 19 mice are from three litters 
derived from the mating of heterozygous fe- 
males to wild-type males. 
(E) Northern blotting of spleen (lanes 1 and 2) 
and thymus (lanes 3 and 4) from wild-type 
(lanes 1 and 3) and ye-‘” (lanes 2 and 4) males with a probe corresponding to the full-length murine Tc cDNA (Cao et al., 1993) or GAPDH. Lanes 
1 and 2, top subpanel, were exposed for 3 days whereas the other three subpanels were exposed for 6 hr. Although a T&reo fusion transcript 
might have been expected (see [A]), this mRNA is apparently unstable. 
(F) Western blotting with R676 antiserum to ys and iysates from spleens (lanes l-3) and thymuses (4-6) from a wild-type male (lanes 1, 4). 
heterozygous female (lanes 2, 5) and yc?’ male (lanes 3, 6). 
plasmic domains This is a more extensive truncation of 
yc than is found in many cases of XSCID in humans (No- 
guchi et al., 1993~; Pucket al., 1993; DiSantoetal., 1994a; 
lshii et al., 1994) and would be expected to result in a 
construct incapable of cell surface expression and lacking 
regions of yc required for signaling. 
Jl strain ES cells were transfected with pPNTrcl .3/2.0 
blotting (a 2% kb band instead of a 7 kb band indicates 
recombination, Figure 1 B) using the Vflanking probe (see 
Figure lA, probe A), and confirmed by hybridization with 
a 3’ flanking probe (data not shown). Hybridization with a 
murine yc cDNA probe corresponding to exons 4-6 con- 
firmed that this region of the gene had been deleted (data 
not shown). Following injection of C57BU6 blastocysts 
with the embryonic stem (ES) cells containing a disrupted 
yc gene, chimeric progeny mice were mated to C57BU6 
mice. ycwN males and heterozygous females derived from 
these and subsequent matings were identified by South- 
ern blotting and polymerase chain reaction (PCR) (Figures 
1C and 1D). Mating of wild-type males to heterozygous 
females yielded wild-type males and females, heterozy- 
gous females, and ‘yc+ males with the expected Mendelian 
frequency. Northern and Western blotting confirmed that 
ye-n males did not express *IC mRNA (Figure 1 E, lanes 2, 
4) or protein (Figure lF, lanes 3, 6) in spleen or thymus, 
but heterozygous females had normal expression of yc 
(Figure lF, lanes 2 and 5). 
Microscopic and Flow Cytometric Analyses of 
lmmunologlcal Organs in y&eflcient Mice 
Heterozygous females and rc-n males, ages 3-9 weeks, 
were similar in size and appearance to age-matched wild- 
type control males and females. No gross lesions were 
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detected in any nonlymphoid organs. As expected based 
on analogy to human XSCID carrier females, heterozy- 
gous female mice had normal lymphoid development and 
were indistinguishable from normal controls. In contrast, 
ye-N males had marked abnormalities, by gross (Figures 
2A and 26) as well as by microscopic (Figure 2; Figure 
3) and flow cytometric (see Figure 4) analyses. They had 
very small thymuses (Figure 2A), and the cortex and me- 
dulla of the thymus of a representative 3-week-old ycen 
male were severely hypoplastic. The cortex was reduced 
in size and the corticomedullary junction was indistinct 
(Figures2D and 2E, compare with normal thymus in Figure 
2C), but the basic thymic architecture was retained. Has- 
sail’s corpuscles were readily identified (Figure 2E, arrow- 
head). In comparison, SClDlNCr mouse thymuses lack 
obvious small lymphocytes and corticomedullary demar- 
cations (Figure 2F). Peripheral lymph nodes were not iden- 
tifiable at necropsy. The mesenteric lymph node was 
small, with a few lymphoid follicles containing small lym- 
phocytes but no germinal centers; paracortical lympho- 
cytes were not obvious (Figures 2H and 21, compare with 
normal lymph node in Figure 26). There was a mild diffuse 
proliferation of spindle cells resembling dendritic cells (Fig- 
ure 21). Gut-associated lymphoid tissue was absent in the 
small and large intestine (data not shown). 
In addition to these histologically defined lesions, Teen 
males had a variety of other immunological abnormalities. 
Based on cell counts and flow cytometric analysis, the 
absolute numbers of all thymic T cell populations defined 
by CD4 and CD8 expression were significantly diminished 
(Table 1; see Figure 4A). Interestingly, there was an in- 
crease in the ratio of CD4+CD8-:CD4CD8+ single-positive 
cells, primarily resulting from an increase in the percent- 
age of the CD4+CD8- population. There was an increase 
in the percentage of thymocytes expressing high levels 
of CD3s, T cell receptor j3 (TCRP), and CD5, but low levels 
of heat-stable antigen (see Figure 4A). Specific gating on 
both CD4+CD8- and CD4CD8’thymocytes revealed that 
they expressed levels of TCR typical of mature single- 
positive cells. Although TCRa8 T cells developed in ycmN 
mice, thymocytes expressing TCRyS were not detected 
in rcen mice even when double-negative CD4CD8- cells 
were specifically examined (data not shown); the presence 
of TCRy5 cells in TcmN fetuses has not yet been assessed. 
As expected, no “IC (TUGm3) expression could be detected. 
Thus, despite the dramatic decrease in lymphoid mass, 
it was striking that mature T cells in fact developed in these 
mice. 
At 3 weeks of age, the spleens of ycN mice were only 
modestly decreased in size (Figure 28). Extramedullary 
hematopoiesis (primarily erythropoiesis), similar to the 
control mouse (Figures 3A and 39) was observed in red 
pulp; however, severe lymphocyte hypoplasia was evident 
in the white pulp of the ycWN male (Figures 3C and 3D; 
Table 1). There was a small accumulation of spindle- 
shaped cells in the periarteriolar lymphoid sheath region; 
the B cell and marginal zones were absent. Flow CytOme- 
tric analysis of the splenic T cells revealed an increase in 
the CD4+CD8-:CD4CD8+ ratio, primarily due to the dra- 
matic decrease in CD4CD8+ cells (Figure 48). The 
CD4+CD8- cells expressed CD3s and CD28 and did not 
appear to represent the MHC class l-educated CD4+ pop 
ulation that has been described (Bendelac et al., 1994; 
Coles and Raulet, 1994; Lantz and Bendelac, 1994) since 
they were not enriched for TCRVj38 (Figure 4B) or CD44 
(data not shown); in fact, the diminished staining by 
TCRV98 and the absence of NKl .l+ cells were consistent 
with a decrease in this population of cells. In contrast, the 
percentages of macrophages/monocytes (Macl+ cells) 
and granulocytes (GRl+ cells) were normal or even in- 
creased. 
Following mitogenic activation with antiCD3, spleno- 
cytes were evaluated for yc, IL-2Rj3, IL-2Ra, and CD89 
expression (Figure 4C). As expected, no yc (TUGm3) ex- 
pression was observed, and while IL-2Rj3 (TMf31) and IL- 
2Ra (7D4) were induced, their levels of expression were 
lower than those seen in the heterozygous female and 
wild-type male. It is possible that the lower IL-2Ra and 
IL-2R8 levels achieved are explained by the lack of IL-2 
and IL-4 responsiveness of Y~-~ mice, since IL-2 (Siegel 
et al., 1987) and IL-4 (Casey et al., 1992) both up-regulate 
IL-2R8 levels and IL-2 (Siegel et al., 1987) up-regulates 
IL-2Ra. Induction of the activation marker CD89 was also 
diminished in the yc+ splenocytes (Figure 4C). One of the 
most remarkable findings in analysis of ycWn spleens was 
that although splenic mononuclear cells were dramatically 
decreased in 3-week-old mice, mice ages 4-9 weeks had 
an apparently age-related increase in splenic lymphocytes 
(Table 1) and enlarged spleens. Each of these animals 
exhibited a markedly increased CD4:CD8 ratio (Table 1). 
The presence of B cells was analyzed by staining bone 
marrow and spleen with 9220, anti-p, and anti-immuno- 
globulin. The ycmn mice exhibited a marked overall de- 
crease in B cells (Table 1). This decrease was most evident 
in the bone marrow where only rare B220+ and B22O+u+ 
cells were present (Figure 4D; Table 1). Although B cells, 
as defined by B220+9+ (Figure 4D) or B220+8+ (data not 
shown) were detected in the spleen, their absolute num- 
bers were markedly reduced as compared with wild-type 
or heterozygous mice (Figure 4D; Table 1) in all ycsn mice, 
regardless of age. Despite this overall decrease in B cells, 
immunoglobulin levels of immunoglobulin M (Igfvl) were 
normal in all mice studied. However, in 25weekold mice 
studied, all other immunoglobulin levels were diminished. 
The decreased levels of IgGl and IgE were expected 
based on the phenotype in the IL&- mice (Kuhn et al., 
1991). The low levels of other classes of immunoglobulin 
as well reflects the greater defect in yc+ mice, consistent 
with the situation in human XSCID (Puck, 1993). 
Cells recovered from the peritoneal cavity were ana- 
lyzed by staining with 8220, CD5, and anti-v (Figure 4D). 
The fraction of B220+ cells that were u* was similar in 
wild-type and yc+ males. Both CD5+p+ and CD5IL+ cells 
were present in the ‘ycmn males (Figure 40) consistent with 
the production of both B-l and conventional B cell popula- 
tions (Kantor and Herzenberg, 1993) analogous to the 
situation in normal mice. B-l cells are “self-replenishing” 
B cellsand can produce all immunoglobulin isotypes, mak- 
ing major contributions to serum IgM, lgG3, and IgA (re- 
viewed by Kantor and Herzenberg, 1993). Therefore, 
Immunity 
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these cells may be contributing to the IgM production in 
the rc-” males. The splenic B cells contained at most a 
minor population of cells expressing CD5 or Mac1 or both 
markers (data not shown), consistent with these cells rep- 
resenting conventional B cells, rather than B-l cells (Kan- 
tor and Herzenberg, 1993). 
Granulocytes (as indicated by GRl+ cells) were readily 
detected in bone marrow (data not shown). Histologically, 
the bone marrow had erythroid hyperplasia, but this was 
similar to that found in the wild-type male and heterozy- 
gous female (data not shown). Analysis of peripheral blood 
mononuclear cells (PBMC) also revealed greatly dimin- 
ished B cells and an absence of NK cells, whereas single 
positive CD4+CD8- cells and Macl+ cells were present 
(data not shown). 
Absence of y6+ DETC and IEL 
One of the most striking findings came from the examina- 
tion of the skin of the hen mice (Figure 5). Immunohisto- 
chemical studies using antibodies to both the y6 TCR 
and the Thyl.2 alloantigen demonstrated that DETC were 
not present in epidermal sheets of 3-, 5-, and 7-week-old 
yc+’ mice (compare Figure 58 with Figures 5A and 5C). 
There was no general lack of Thyl.2 alloantigens in the 
epidermis as keratinocytes expressed this antigen on their 
cell membranes(Figure 5E). Other dendritic epidermal cell 
populations, such as Langerhans cells, were present in 
normal density (Figures 56-51). The absence of 76’ cells 
in the skin prompted us to also examine the intestines for 
y6+ IEL. The fact that these cells were also absent in mice 
lacking yc expression (data not shown) was interesting, 
particularly since in contrast with the y6+ cells of the skin, 
a significant proportion of yS+ IEL are extrathymically de- 
rived (reviewed by Lefranpois, 1994). 
Immune Function in the yc-Deficient Mice 
The functional capabilities of T cells were next evaluated. 
The most striking feature was that thymocytes from ye-N 
males were capable of responding to phorbol myristate 
acetate (PMA) plus ionomycin or to anti-CD3 plus anti- 
CD28 as potently as were age-matched controls (Table 
2). Consistent with the absence of yc, which is required 
for IL-4 signaling in T cells (Kondo et al., 1993), the thymo- 
cytes from yc-Iy mice could not proliferate in response to 
PMA plus 11-4, in marked contrast with wild-type mice and 
heterozygous females (Table 2). Splenocytes from yc-Iy 
Figure 2. Histological Abnormalities in Thymus and Lymph Nodes from Q’ Mice 
Photographs of thymuses (A) and spleens (6) from 3-week-old wild-type and y.-” (arrowhead) males. 
(C) Thymus of wild-type mouse with normal morphology and a distinct corticomedullary junction (arrow; hematoxylin and eosin, 20 x). 
(D) Thymus of ycmn mouse with a less well-defined coritcomedullaty junction but retaining a subscapsular rim of lymphocytes. A cyst is present. 
(Hematoxylin and eosin, 20x). 
(E) Thymus of y;‘” mouse showing small subcapsular lymphocytes (arrow) and a Has&l’s corpuscle (arrowhead; hematoxylin and eosin. 50 x). 
(F) Thymus of SClDlNCr mouse, in which small lymphocytes are not present and there is no cortiwmedullary junction (hematoxylin and 
eosin, 50 x). 
(G) Lymph node of wild-type mouse containing follicles (arrow) with active germinal centers (hematoxylin and eosin, 13.2 x). 
(H) Lymph node of ycY mouse with small inactive follicles (arrow) and fewer paracortical lymphocytes than the wild-type mouse (hematoxylin and 
eosin, 13.2 x). 
(I) Lymph node of a y.? mouse with an inactive follicle (arrow) and adjacent spindle-shaped cells that resemble dendritic cells (hematoxylin and 
eosin, 33 x). 
mice also responded to PMA plus ionomycin and anti-CD3 
plus anti-CD28 (Table 3), but in contrast with the situation 
for thymocytes, the response was much less potent than 
that seen with age-matched controls. Splenocytes from 
Y~-~ mice also responded to lipopolysaccharide, but again 
to a substantially lower degree than did normal controls 
(Table 3). Consistent with the importance of yc for IL-4 
responses, we were unable to detect a significant re- 
sponse to IL-4 plus anti-p in Y;~ splenocytes (Table 3). 
In some experiments, a modest response to PMA plus 
IL-4 was also observed (data not shown), suggesting the 
possibility of yc-independent IL+mediated signaling, 
analogous to the situation in THP-1 cells (Kotanides and 
Reich, 1993) and in COS-7 cells (Lin et al., 1995). In a 
preliminary experiment, we also assessed the ability of 
IL-4 to augment survival of purified T cells. Whereas cells 
from normal males and heterozygous females exhibited 
enhanced survival at day 1 and a 5 to lo-fold increase 
in survival at day 4, cells from a yc-‘” male did not (data 
not shown). 
We next examined the ability of anti-CD3 plus anti-CD28 
to stimulate production of cytokines. In comparison to nor- 
mal littermates, interferon-y (IFNy) production wasdramat- 
ically reduced (1019.3 f 432.9 U/ml in controls versus 
1.8 f 0.2 in yen males [p < .OOOl]). Both IL-2 and IL-4 
production was stimulated, but to only 35%-400/b of nor- 
mal levels (IL-2 production was 13.0 f 2.7 for controls 
versus 5 f 0.9 for yceN males [p = .0595]; IL-4 production 
was 98.7 + 13.5 for controls versus 35.5 f 11.8 for Q’ 
males [p = .0223]). In the normal mice, cytokines were 
produced at much lower levels by thymocytes than by 
splenocytes, but no IFNy, IL-2, or IL-4 were produced by 
ycmN thymocytes in any experiment. Finally, to assess mast 
celllbasophil function in the spleen, we examined the abil- 
ity of plate-bound IgE plus IL-3 plus WEHI supernatant to 
induce IL-4 production. The ycZ’ mice exhibited height- 
ened responses, with levels of IL-4 production approxi- 
mately lo- to 45-fold elevated compared with normal lit- 
termates. This may partly be explained by the diminished 
levels of serum IgE in yc+ mice, resulting in more FcERI 
on the surface of cells being available for cross-linking by 
immobilized IgE; in addition, it is possible that the cells 
capable of responding represent a higher percentage of 
splenocytes in ‘ycY males. 
To confirm the absence of NK cells suggested by the 
absence of NKl l+ cells, we analyzed the cytolytic activity 
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Figure 3. Histological Abnormalities in Spleen and Cecum from ycP Mice 
(A and 6) Spleen of wild-type mouse. Red pulp has extramedullary hematopoiesis; white pulp (arrow) has normal morphology (hematoxylin and 
eosin, 13.2x, 33x). 
(C) and (D) Spleen of Y.-deficient mouse. Red pulp has extramedullary hematopoiesis; white pulp (arrow) has severe lymphocyte depletion (hematoxy- 
lin and eosin, 13.2x, 33x). 
(E) Cecum of wild-type mouse, with normal sized crypts (hematoxylin and eosin, 80 x). 
(F) Cecum of Y.-deficient mouse with proliferative typhlitis. Crypt height is increased and there are increased mononuclear cells in the lamina 
propria (hematoxylin and eosin, 60 x). 
(G) Cecal crypts of ycdeficient mice with tangled mats of helical bacteria (Steiner stain, 160x). Arrow indicates H. hepaticus. 
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of splenocytes against YAC-1 targets at varying effector- 
to-target cell ratios. Whereas NK activity in fresh cells from 
wild-type mice and heterozygous females was 16 f 4 lytic 
U/10’ cells, cytolytic activity in cells from yc+ males was 
indistinguishable from 0. As expected, IL-2 activated cyto- 
lytic activity in the control animals but not in theyceN males 
(data not shown), consistent with the requirement of yc for 
IL-2-induced cellular responsiveness. 
Inflammatory Bowel Lesions 
Proliferative typhlitis (inflammation of the cecum) and coli- 
tis with deeper crypts (see Figures 3E and 3F) was ob- 
served in ycTn males but not in heterozygous females or 
wild-type males. In the ycmn males, mitoses were seen 
higher on the crypts, and mucosal infiltrates of mononu- 
clear cells and neutrophils were present. These lesions 
were accompanied by the presence of helical bacteria in 
the crypts and lumen of the cecum and colon (Figure 3G). 
In this regard, it may be relevant that Helicobacter hepat- 
icus, a newly recognized pathogen of mice that causes 
chronic active hepatitis (Ward et al., 1994) has been asso- 
ciated with inflammatory bowel lesions in immunocom- 
promised mice including SClDlNCr mice and nude mice 
(Russell et al., 1995; Ward et al., unpublished data), but 
not in C57BU6 mice, which are resistant to development 
of gut and liver lesions even when the large intestine is 
colonized with H. hepaticus. There was no evidence of 
crypt abscesses, mucosal ulcerations, or granulomatous 
inflammation of the bowel wall in 3, 5-, and 7-weekold 
animals as are found in human inflammatory bowel dis- 
ease. Whether such lesions might become evident later 
in life, analogous to those of the IL-2-‘- mice (Sadlack et 
al., 1993), is not yet clear. 
Discussion 
The phenotype of yc? mice underscores the importance 
of “(c in lymphoid development. These mice had small hy- 
poplastic thymuses, with greatly reduced cortical and 
medullary regions; however, a cortical rim of small lympho- 
cytes was seen and Hassall’s corpuscles could be identi- 
fied. In canine XSCID, in which a 4 bp deletion in the first 
exon of the yc gene prevents production of a functional 
protein (Henthorn et al., 1994) the thymuses were dys- 
plastic, albeit variable in extent, with Hassali’s corpuscles 
being present in approximately half the animals studied 
(Snyder et al., 1993). In this sense, canine XSCID initially 
might appear to be more similar to our yc+ mice than to 
humanXSCID, in which thymic development has tradition- 
ally been described as dysplastic, with a complete lack of 
Hassall’s corpuscles. More recently, however, some het- 
erogeneity has been described for humans as well 
(Gosseye et al., 1963; Nezelof, 1966). However, the extent 
of thymic development in healthy XSCID humans remains 
somewhat unclear since few of the human SCID cases 
represent definitively proven cases of XSCID; the tissue 
samples are often from autopsy specimens of children 
who died of overwhelming infection; and even biopsyspec- 
imens were presumably obtained from children who came 
to medical attention because of opportunistic infections. 
In addition, it is reasonable to assume that thymic develop- 
ment may be influenced by other genetic factors as well, 
and that humans with different yc mutations, which are 
variable in their extent of inactivation of yc function, will be 
differentially affected. Indeed, an atypical case of XSCID 
(DiSanto et al., 1994b) and a family with moderate X-linked 
combined immunodeficiency (Brooks et al., 1990; Russell 
et al., 1994; Schmalstieg et al., 1995) have peripheral T 
cell development quite different from that found in classic 
XSCID. 
XSCID dogs consistently exhibited a normal CD4:CD8 
ratio in the thymus (Somberg et al., 1994), whereas we 
reproducibly have found the ratio to be increased. In both 
dogs and mice, the CD4:CD8 ratio was increased in the 
periphery. Canine peripheral lymphocytes demonstrated 
a profoundly diminished phytohemagglutinin response, 
but the proliferative capacity of thymocytes was not evalu- 
ated (Somberg et al., 1994). In the yc?mice, the thymo- 
Figure 4. Flow Cytometric Analysis of Thymocytes, Splenocytes, Bone Marrow, and Peritoneal Cells from yE-n Mice 
(A) Flow cytometric analysis of thymocytes from Sweek-old mice (heterozygous female, wild-type male, and ys-” male). For two-color histograms, 
the percentages of CD4+CD8-, CD4+8+, and CD4CD8’ cells are indicated in the appropriate quadrants. For one-color histograms corresponding 
to surface expression of CD3s, TCRf3, CD28, CD5, and heat-stable antigen, thymocytes were directly stained with conjugated antibodies; the 
shaded region represents staining with similarly conjugated control antibodies. Expression of y. was assessed by indirect immunofluorescence; 
the shaded region represents staining with goat anti-rat immunoglobulin-PE alone. 
(B) Flow cytometric analysis of splenocytes from the same 3-weekold mice analyzed in (A). For the two-color histograms with anti-CD4 and antiCD8, 
the numbers represent the percentage of cells in the boxed regions. To analyze CD4’ cells specifically, splenocytes were stained with anti-CD4 
and anti-CD8 and software gating was used to examine expression of CD3s, TCRVf38, and CD28 by CD4+CD8- (CD4’) cells (left). In addition, 
ungated total splenocyte populations were assessed for expression of CD5, NKl .l , Macl, and Grl cell surface molecules (right). In both cases, 
cells were directly stained and shaded regions represent staining of appropriately gated populations of cells with control antibodies. 
(C) Expression of y., IL-2Ra, IL-2R8, and CD89 on activated splenocytes. Unseparated splenocytes were cultured with soluble antiCDb (145-2Cll) 
and stained with antibodies directed against the indicated cell surface molecules. To assess yc and IL-2Rj3 expression, cells were cultured for 3 
days in the presence (stimulated, S) or absence (resting, R) of antiCD3c. Cells were harvested and stained with unconjugated anti?, (TUGm3) 
or anti-IL-2Rf3 (TM81), followed by the addition of goat anti-rat immunoglobulin (GaR)-PE. The shaded area represents staining of activated cells 
with GaR alone. After 3 days, most B cells have died; hence, the majority of cells represent T cells. To assess IL-2Ra and CD89 expression, cells 
were cultured for 18 hr in the presence or absence of anti-CD3s and directly stained with anti-IL-2Ra (7D4) or antiGD89. Histograms represent 
staining of Thyl.2 gated T cells. Shaded areas represent staining of equivalently gated activated cells with control antibodies. 
(D) B cell development in y;” mice. Bone marrow and spleen were obtained from the same mice whose profiles are shown in (A-C). Peritoneal 
cells are representative of those obtained from three independent sets of animals. Cells were stained with antibodies directed against the indicated 
cell surface molecules (8229, tt, and CD5). The percentages of cells within quadrants of interest are indicated. These percentages do not represent 
absolute numbers of B cells, as fewer total cells were analyzed from the ysmn mouse. 
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Figure 5. Absence of yS+ DETC but Retention of Langerhans Cells in @’ Mice 
DETC are absent in epidermal sheets of ycdeficient male mice. Epidermal sheets from wild-type males (A, D, G), from ys-N mates (S, E, H), and 
frOmI heterozygote (Ye+“) females (C, F, I) were assessed for the presence of DETC and Langerhans cells. Normal densities of ~8 TCG+ dendrtttc 
cells were seen in the normal (A) and heterozygote (C) mice but no y6 TCR’ cells were seen in the epidermis of the ye-r+ mice (6). Anti-Thyt.2 
MAb stained keratinocytes in all three specimens, but only stained DETC in normal (D) and heterozygote (F) mice. Normal densities of Langerhans 
cells are seen in skin from the three different mice (G, H, I). Scale bar, 45 pm. 
cytes gave the most reproducible responses to T cell mi- 
togens. 
Corresponding to the lymphoid hypoplasia in the thy- 
muses of mice lacking “~c expression, there was also se- 
vere lymphoid hypoplasia in the spleens of the 3-week-old 
animals examined. The slightly older animals (4-9 weeks 
of age) had an age-related increase in splenocytes (Table 
1). Although the basis for the difference is unknown, it is 
possible that the retarded populating of the spleen with T 
cells is explained by the small size of the thymus with 
a concomitant decreased rate of egress of cells to the 
periphery. These findings are interesting in view of the 
normal thymic and T cell development observed in mice 
lacking production of IL-2 (Schorle et al., 1991), IL-4 (Kuhn 
et al., 1991), or both IL-2 and IL-4 (Sadlack et al., 1994) 
indicating that the loss of signaling in response to cyto- 
kines besides IL-2 and IL-4 is responsible for the defects 
in mice lacking “IC expression. However, it was particularly 
striking that there was significant T cell maturation in Ye+” 
mice, indicating that pathways not mediated by ycdepen- 
dent cytokines are sufficient to achieve significant devel- 
opment. In this regard, it is interesting that mice lacking 
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Table 2. Thymocyte Proliferation0 
Experiments 
Experiment 1 
Experiment 2 
Experiment 3 
Experiment 4 
Age Genotype 
3 weeks +N 
3 weeks -N 
3 weeks -N 
5 weeks +I- 
5 weeks -N 
3 weeks i/y 
3 weeks +I+ 
3 weeks -N 
3 weeks +p/ 
3 weeks -N 
5 weeks +I- 
5 weeks -N 
3 weeks +N 
3 weeks +I- 
3 weeks -N 
RPM PMA + IL-4 PMA + lonomycin Anti-CD3 + Anti-CD28 
95 f 22 15752 f 3160 22593 f 2423 
91 f 56 62 f 20 33458 f 424 
182 f 82 198 + 28 32630 f 1532 
39 + 17 21668 f 880 30294 f 1722 
25 f 6 34 f 23 22359 f 1471 
68 f 20 11892 f 1242 6937 f 573 
101 f 87 11907 f 1182 6811 f 1104 
98 f 57 62 f 16 6463 f 405 
76 + 6 60288 f 4750 
56 + 2 66751 f 412 
56 + 9 74868 f 9058 
95 f 22 83140 f 3570 
36 f 9 50360 f 4227 
46 2 20 42546 f 1789 
62 f 22 85148 f 8376 
’ Data are expressed as mean + SD. 
PHjthymidine uptake in thymocytes stimulated with PMA plus IL-4, PMA plus ionomycin (Experiments 1 and 2) or anti-CD3 plus anti-CD28 
(Experiments 3 and 4). We used 2.5 x IO’ cells/well in Experments 1 and 2, and 1 x 105 cells/well in Experiments 3 and 4. The animals are 
identified by age and genotype. 
IL-7 receptor expression exhibit a more severe phenotype 
than is seen in the ‘ye-N males, with thymic development 
being even more blunted with a relative block at the dou- 
ble-negative stage (Peschon et al., 1994). Although the 
basis for the more severe phenotype in IL-7R-‘- mice is 
unclear, it may be important that a second stromal cell- 
derived cytokine, denoted thymic stromal-derived lympho- 
poietin (TSLP) (Peschon et al., 1994) shares a number of 
actions with IL-7. The TSLP receptor contains the IL-7R 
(Peschon et al., 1994) and hence both IL-7 and TSLP 
should be inactive in IL-7R-‘- mice. However, it is not yet 
known whether yc is required for TSLP action. If not, then 
it is conceivable that TSLP (or other y,-independent cyto- 
kines) could be responsible for the T cell development and 
T cell proliferation seen in ycmn mice. 
The ycmN mice exhibited a marked overall decrease in 
conventional B cells. In the spleen, while some animal-to- 
animal variation was found, all exhibited marked decreases 
in B cells. Moreover, there was consistently a marked de- 
crease in B cells in peripheral blood and bone marrow. 
These findings are in contrast with the situation in humans 
(Conley, 1992; Leonard et al., 1994) and dogs (Felsburg 
and Somberg, 1992) with XSCID, where the B cell num- 
bers are not diminished. The overall decrease in B cells 
in mice is perhaps explained by the apparently greater 
role for IL-7 in mice than in humans (discussed by Leonard, 
1994) suggested by studies in which mice were treated 
with a monoclonal antibody (MAb) to IL-7 (Grabstein et 
al., 1993). IL-7RV mice also exhibit depressed levels of 
peripheral B cells (Peschon et al., 1994) although in these 
mice the decrease may result from the simultaneous func- 
tional inactivation of both IL-7 and TSLP. In any case, the 
greater severity of the B cell defect in yc-ly mice than in 
humans with XSCID suggests that B cell development is 
more dependent on y,-dependent cytokines in mice than 
in humans. The defective production of conventional B 
Table 3. Splenocyte Proliferation to LPS, IL-4 + Anti-u, PMA + lonomycin, and Anti-CD3 + Anti-CDPS’ 
Exoeriments Ace Genotype RPM1 LPS IL-4 + Anti-u PMA + lonomycin Anti-CD3 + Anti-CD28 
Experiment 1 3 weeks +-I- 1114 f 88 166045 f 4288 19356 f 1218 
3 weeks +I+ 1041 f 288 149823 f 3860 28944 f 1037 
3 weeks -N 680 f 62 12009 f 672 952 f 99 
3 weeks -N 842 f 61 519s f 105 817 f 76 
Experiment 2 3 weeks +N 390 f 50 122527 f 116 8405 f 602 
3 weeks +I- 387 f 57 124698 f 4966 9288 f 278 
3 weeks -N 120 f 8 19711 f 2748 189 f 59 
Experiment 3 3 weeks +N 1124 2 302 12OS47 f 5157 105579 f 1339s 
3 weeks -N so9 f 107 21436 f 1535 7357 f 2407 
3 weeks -N 1698 + 1109 23028 f 551 5664 f 341 
5 weeks i/-k 711 f 125 98225 f 5267 84345 f 12290 
5 weeks -N 613 -c 242 10890 f 781 3801 f 764 
6 weeks -N 1124 f 220 23989 f 2140 6212 f 1240 
a Data are shown as mean f SD. 
PHjthymidine uptake in splenocytes stimulated with lipopolysaccharide, IL-4 plus anti-u (Experiments 1 and 2) or with PMA plus ionomycin and 
anti-CD3 plus anti-CD28 (Experiment 3). Cells (lOS/well) were used in Experiments 1 and 3, and 5 x IO’ cells/well were used in Experiment 2. 
The animals are identified by age and genotype. 
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cells in mice and the presence of peritoneal B-l B cells 
lends support to the idea that these populations of B cells 
emerge from distinct precursors. 
The complete absence of Thy-l + dendritic epidermal T 
cells was striking. T cells expressing yS T cell receptors 
are the earliest appearing TCW cells in thymic ontogeny 
(reviewed by Allison and Havran, 1991). Cells expressing 
yS TCR appear at day 14, and until day 18 constitute the 
major class of TCR+ cells in the thymus. Moreover, they 
are the dominant lymphoid population in certain epithelial 
tissues, including the skin (Allison and Havran, 1991). 
These DETCs are exclusively Vy3-VSl and, when cul- 
tured, are known to produce a variety of cytokines, includ- 
ing IL-1 a, IL-2, IL-3, IL-8, IL-7, IFNY, GM-CSF, tumor necro- 
sis factor a, and tumor necrosis factor p (Bergstresser et 
al., 1993). IL-2 does not induce proliferation by itself, but 
it is an important cofactor for proliferation of these cells 
in vitro (Tschachler et al., 1989). Moreover, IL-2 transgenic 
mice exhibited an increased number of dendritic epider- 
mat T cells (Ishida et al., 1989), and in utero treatment 
with a blocking MAb to murine IL-2RP completely abro- 
gates their development (Tanaka et al., 1992), but not the 
development of afl TCR’ cells nor y6 TCR’ cells in the 
intestinal epithelia (Tanaka et al., 1992). In this regard, it 
is interesting that IL-PRP expression is largely restricted 
to y6 cells in day 17 fetal thymus (Tanaka et al., 1992), 
including the precursors of those cells that target to the 
skin (Havran and Allison, 1990). This suggests that IL-2 
or IL-15 (whose receptor also contains IL-2RP [Bamford 
et al., 1994; Giri et al., 1994]), or both, may be essential 
for the growth and/or migration of these cells. Further- 
more, IL-7 is also an important growth factor for DETC 
(Matsue et al., 1993). The fact that IL-2, IL-7, and IL-15 
signaling requires 7/c (Takeshita et al., 1992; Noguchi et 
al., 1993b; Kondo et al., 1994; Giri et al., 1994; reviewed 
by Leonard, 1994) therefore provides a possible explana- 
tion for the absence of y6 cells in yceN mice. In this regard, 
it is noteworthy that in normal mice, “IC mRNA is expressed 
in thymocytes as early as day 13.5 (the earliest point exam- 
ined; C. Sommers et al., unpublished data), consistent 
with yc being present in the thymus at least as early as the 
first yS cells. It is interesting that mice lacking expression of 
p5Wk exhibit a block in development of yS cells in the 
thymus, but have normal levels of yS IEL (Penninger et 
al., 1993), suggesting a more important role for *~c than 
~58”~ in the development of IEL. 
The fact that the heterozygous females exhibited normal 
lymphoid development and function was consistent with 
the normal phenotype of human heterozygous “carrier” 
females who exhibit strictly nonrandom X chromosome 
inactivation patterns in their mature T cells, NK cells, and 
B cells (Conley, 1992). Thus, the mature lymphocytes in 
heterozygous female mice may be cells in which the X 
chromosome with the mutated yc gene was inactivated, 
thereby resulting in normal levels of yc expression in the 
cells. However, formal X-inactivation studies in these ani- 
mals could prove interesting in view of the extent of T cell 
development in ycWN mice, a finding consistent with the 
possibility that some murine T cell populations with a mu- 
tated yc have a greater chance for survival than do the 
corresponding cells in humans with XSCID. 
These ycen mice provide a valuable in vivo model not 
only for mapping functional domains of yc by establishing 
yc transgenic lines with specifically designed mutations, 
but also for evaluating gene therapy approaches that have 
worked in vitro (Qazilbash et al., in press). As compared 
with SCID mice, ye-n mice have greater T and B cell devel- 
opment. A striking difference, however, is their total ab- 
sence of NK cells, whereas SCID mice have normal to 
enhanced NK activity. The absence of NK cells could make 
these mice extremely valuable as a model system for treat- 
ing transplanted malignancies in a setting unencumbered 
by endogenous NK activity. 
Experimental Procedures 
Sequencing and Mapping of the Murine yC Gene 
The murine yc gene was isolated from a 129 genomic library in A-FIX 
(Stratagene). An 802 bp probe corresponding to the 5’ end of the 
muriney, cDNA(Cao et al.. 1993) was prepared by PCR using primers 
corresponding to nucieotides 20-42 (5’-GCACCATGlTGAAACTAT- 
TATTG9’, top strand) and 820-799 (5’~TAATCAACCCCATGGTGC- 
CMC9’, bottom strand). One genomic clone (clone 8B) contained a 
15 kb Not1 fragment spanning the entire gene (see schematic in Figure 
1). A7 kb Hindiii subfragment containing all eight exons was subcloned 
into pBluescript (piasmid denoted pBSrc7.0), and a 5267 bp region 
spanning the putative promoter, eight exons, and seven introns was 
sequenced using Sequenase 2.0 (United States Biochemical Corpo- 
ration). 
Preparation of the Targeting Construct 
The 2 kb BamHl fragment extending from the BamHi site just 3’ of 
exon 8 into the plasmid polylinker was excised from the pBSv.7.0 (see 
above section). This fragment was then cloned into pPNT (Tybuiewicz 
et al., 1991) at the BamHi site immediately 3’to the neo gene and 5’ 
to the herpes simplex virus-thymidine kinase (hsv-t/o gene. Both the 
neoand &genes in this plasmid are under control of the PGK promoter. 
The resulting plasmid was denoted pPNT7,P.O. pBSy,7.0 was then 
digested with BamHi and EcoRV to liberate a 1.3 kb fragment ex- 
tending from the BamHi site 5’ of exon 1 to the EcoRV site in exon 3 
(see Figure 1). This fragment was cloned into peiuescript SK+ between 
the BamHi and EcoRV sites (thereby generating the plasmid 
pBSy,l.3). The piasmid was linearized with EcoRV, Noti linkers added 
and digested with Noti, which cleaved in the linkers as well as in the 
Notl site 5’in the poiylinker. This Noti fragment was cloned in the Noti 
site of pPNTy,P.O (upstream of the neo gene). The presence of this 
fragment then allowed sequential digestion with Xhoi and Notl (prior 
to cloning a fragment into the Noti site, the Xhol and Not1 are tot closely 
positioned to be simultaneously digested), resulting in the removal of 
the Notl fragment just cloned, and the Notl to Xhol fragment from 
pBSy,l.S was then cloned into this position to generate the final 
pPNTy,l.3/2.0 targeting construct that could be linearized with Notl. 
ES ceils and Transfections 
Jl ES cells (passage 12) were propagated on mitomycin C-treated 
mouse embryonic fibrobiasts in culture media supplemented with 1000 
U/ml leukemiainhibitoryfactor(GiBC0 BRL). ESceilsweretrypsinized 
and resuspended in electroporation buffer. The targeting construct, 
pPNTy,l.3/2.0 (25 ug) was linearized and transfected by eiectropora- 
tion into 1 x lo7 ceils in a .4 cm Gene Pulser (Biorad) cuvette at 400 
V, 25 pF. Electroporated cells were plated at a a density of 2.5 x l(r 
cells/60 mm plate on neo’ fibroblasts obtained from TCR<+‘- embryos 
(Love et al., 1993). Positive-negative selection was started 24 hr after 
transfection using G418 (GIBCO, 350 pglml [dry weight]) and gan- 
cyclovir (2 PM). Transfection efficiency was estimated by selection in 
media containing G418 alone. 
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Identification of y.-Deficient ES Clones and Generatlon 
of y.-Deficient Ylcs 
Surviving ES clones were expanded and frozen, DNA prepared (Laird 
et al., 1991), digested with Hindlll, and subjected to Southern blotting 
using a probe corresponding to the 1.2 kb Sflanking Hindlll to BamHl 
fragment from pBS-yc7.0 (Figure 1 A, probe A). Filters were hybridized 
at 42OC with 50% formamide, 5 x SSPE, 5 x Denhardt’s solution, 200 
pg/ml salmon sperm DNA, 0.1% SDS, 10% dextran sulfate, and lo8 
cpm/ml of probe. This probe hybridized to a 7 kb band in the normal 
gene and a 2.5 kb band (see Figure 1 A) in the clones in which homolo- 
gous recombination had occurred. Since ES cells are male and h 
is located on the X chromosome, a single recombination event was 
sufficient to generatey,deficient ES cells. Out of 341 clones screened, 
3 vc-deficient clones were identified. Cells from these clones were 
injected into C57BU6 blastocysts (15-20 cells/blastocyst), which were 
implanted into C57BU6 pseudopregnant foster mothers. Assessed by 
coatcolor, 12chimericprogeny(lOfemalesand 2 males)were mutated 
to C57BU6 mice; 1 chimeric female by germline transmission gave 
birth to asingle@ male, and chimeric males fathered multiple hetero- 
zygous females, which in turn gave birth to additional ye-“’ males and 
heterozygous females. ycen males and heterozygous females were 
detected by Southern blotting as described or by nested PCR using 
two sets of primers in which the top strand primer was located in yc 
and the bottom strand primer was located in the neo gene. First set, 
h 5%AlTCCAGGAGTGCAGTCACTAllTG-3’, two, S%CTGACAG- 
CCGGAACACGGCGG-3’; second set, yc C’-CTCCAA AGAGAT- 
TACTTCTGGCTGTC-3’, neo, 5%ATTGTCTGlTGTGCCCAGTCAA 
GCC-3’. Genomic DNA (200 ng) was used as the template for the first 
PCR (94‘C for 2 min. then five cycles of 95OC for 1 min, 50°C for 1 
min, and 72OC for 2 min, then 30 cycles of 95OC for 1 min, 65OC for 
1 min. 72OC for 2 min, then 72°C for 10 min prior to cooling to 4’C). 
For the second PCR reaction, 2 ~1 of the first PCR reaction was used 
as the template (94OC for 2 min, then five cycles of 95OC for 1 min, 
50°C for 1 min, and 72OC for 2 min, then 20 cycles of 95’C for 30 S, 
65OC for 30 s, 72OC for 45 s, then 72°C for 10 min prior to cooling 
lo 4OC). 
Northern Blotting and Weetsrn Blotting 
Northern blotting was performed using 5 ug of total RNA by standard 
methods as previously described (Love et al., 1994). Western blotting 
was performed using lysates from 1 .O x 1Q cells per lane and R676 
antiserum to yc and enhanced chemiluminescence (Amersham). Al- 
though R676 was prepared using a peptide derived from the C termi- 
nus of human yc (Noguchi et al., 1993b; Russell et al., 1993), it also 
recognizes murine y* 
Pathology 
Complete necropsy examinations were performed on three represen- 
tative 3-week-old mice: a Q’ male, a wild-type male, and a heterozy- 
gous female. Tissues were fixed in 10% neutral buffered formalin, 
processed through alcohols and xylene, embedded in paraffin, sec- 
tioned at 5 pm, and stained with hematoxylin and eosin. Gut sections 
were also stained with the Steiner modification of the Warthin-Starry 
stain for H. hepaticus. 
Immunoperoxldaee Staining of Frozen Sectlons 
Intestines were dissected, placed in OTC freezing medium (Miles, 
Elkhart, Indiana) and frozen on dry ice. Sections (10 pm) were placed 
on silanated slides, dried overnight, and fixed for 15 min in cold ace- 
tone. Slides were stored with desiccant at -8OOC. All incubations were 
carried out at room temperature. For immunoperoxidase staining, tis- 
sue sections were rehydrated in phosphate-buffered saline (PBS) and 
nonspecific binding sites blocked by incubating for 30 min in PBS 
with 2% normal mouse serum and 3% normal goat or rat serum. The 
blocking solution was removed and the tissue sections were incubated 
for 60 minutes with hamster anti-mouse 6 chain (GL-3, PharMingen) 
or control MAbs in PBS with 2% goat serum, washed in PBS, and 
then incubated for 60 min with biofinylated goat anti-hamster IgG (Vec- 
tor Labs). Alternatively. they were stained with biotinylated rat anti- 
mouse CD4 (RM4-4, PharMingen). The sections were washed three 
times for 30 min in PBS, incubated for 30 min with strepatavidin- 
horseradish peroxidase (Zymed Laboratories), washed six times for 30 
min in PBS, and incubated with 0.5% (whrol) of 3.3 diaminobenzidine 
(Sigma), 0.05% NaCI, and 0.03% H&. Sections were rinsed in PBS, 
counterstained with 5% methyl green (Fisher Scientific) in methanol, 
rinsed in distilled water, air dried, and mounted with Permount (Fisher 
Scientific). 
Aeeeeement of DETC and Langerhenr Cell Densities 
In Epidermsl Sheet Pmoarstlonr 
Ears were removed from 3,5, and ‘I-week-old mice and dorsal and 
ventral sides were separated with forceps. Each side was incubated 
at 37’C in 0.1 M NH,SCN for 20 min. after which the epidermal sheets 
were separated from the dermis. The sheets were washed in PBS, 
fixed in acetone for 30 min at -20°C, and washed again in PBS prior 
to staining. Sheets were then incubated in a moist chamber at 37OC 
for 2 hr with one of the following fluorescein isothiocyanate (FITC)- 
conjugated reagents: hamster anti+ TCR, rat anti-Thy 1.2, or their 
respective isotype controls at 10 pglml (PharMingen, San Diego, Cali- 
fornia) or Y3P (mouse anti-I-Ab) or MK-D6 (mouse anti-l-Ad) at 15 @ml 
(American Type Culture Collection, Rockville, Maryland). The sheets 
were then washed and mounted on slides and viewed using fluores- 
cence microscopy. 
Flow Cytometric Analyees 
Cells from thymus, spleen, bone marrow, and PBMC were stained 
primarily with directly conjugated antibodies and analyzed on a FACS- 
can (Becton Dickinson) using Lysis II software. Data on 5-50 x 103 
viable cells (as determined by forward versus side scatter) were col- 
lected for each sample. For multicolor analyses, cells were first incu- 
bated with 2.462 MAb to the Fc receptor (Unkeless, 1979) lo prevent 
nonspecific binding. For two- and three-color analyses, cells were se- 
quentially incubated with FITC-conjugated MAb, phycoerythrin (PE)- 
conjugated MAb, and biotinylated MAbs, and then with Red 670 strep- 
tavidin (GIBCO BRL). For two-color analyses, the numbers indicate 
the percent of cells in each quadrant. For one-color analyses, the 
shaded regions represent staining with the control antibody. The con- 
trol antibodies included mouse IgG2aconjugated to FITC or PE (Phar- 
Mingen, San Diego, California), or Leu4 conjugated to biotin (Becton 
Dickinson). For direct staining, the following conjugated antibodies 
were purchased from PharMingen (San Diego, California): 53-6.7- 
FITC (anti-CDS), 5OO.A2-FITC (anti-CD&). Gr-1 (specific for granulo- 
cyte and monocytes), Ml170 (MAC-l, anti-CD1 1 b). H1.2F3-FITC (anti- 
CD69), 7D4-FITC (anti-IL-2Ra), PK136-PE (anti-NKl.l), RMQ5-PE 
(anti-CD4), H57-597-PE (anti-TCRB), 37.51-PE (antiCD28). 53-7.3- 
PE (anti-CD5), M1/69-PE (anti-heat-stable antigen). In additon, Fg.l 
(anti-TCRVg8) was purified and conjugated to FITC in our laboratory. 
For indirect staining, cells were reacted with unconjugated TUGm3 
(provided by Dr. K. Sugamura) or TMBI (provided by Drs. T. Tanaka 
and M. Miyasaka), washed, and stained with goat anti-rat-PE (South- 
ern Biotechnology Associates, Birmingham, Alabama). 
Cytotoxlclty Assay 
Cytotoxicity assays was performed as described (Bloom and Horvath, 
1994) against YAC-1 target cells, using doubling dilutions of effector 
cells beginning with an effector:target cell ratio of 1OO:i for unstimu- 
lated cells, and a 5O:l for cells stimulated at 2 x iv/ml for 44 hr 
with 1000 U/ml human recombinant IL-2 (Amgen, Thousand Oaks, 
California). A lytic unit (LU) is the number of effector cells lysing 20% 
of the target cells. Data are expressed as LU in 10’ effector cells f 
asymptotic SEM (Bloom and Korn, 1983). 
Serum lmmunoglobulln Levels 
Serum IgM, IgGl, IgG2a, IgG2b, lgG3. IgA, and IgE were measured 
by enzyme-linked immunosorbent assay. Goat anti-mouse coating an- 
tibodies and alkaline phosphatase-conjugated second antibodies for 
IgM, IgGl, IgGPa, IgG2b, lgG3, and IgA were from Southern Biotech- 
nology Associates. Biotinylated second antibodies for IgE were from 
PharMingen, respectively. Horseradish peroxidase avidin (Vector) and 
ABTS peroxidase (Kirkegaard and Perry Laboratories) were used to 
develop the IgE assays. 4-methylumbellifetyl phosphate (2 x lo-’ 
M) in MUP buffer (0.05 M NaHC03, 1 mM MgCI,. Ol.% NaNd was 
used to develop IgM, IgGl, IgGPa, IgG2b, and lgG3. 
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Cytokino Production and Cellular Proliferation 
For cytokine production, wells of Q8-well flat-bottomed plates were 
coated with anti-CD3 (2Cl1, IO pg/ml) overnight at 4OC in PBS, 
washed, and anti-CD28 ascites (1:500 dilution) added along with thy- 
mocytes or unfractionated splenocytes (l-2 x 106 cells/well). IFNy 
was measured on 48 hr supernatants and IL-2 and IL-4 on 24 hr super- 
natants. IL-2 and IL-4 were measured by bioassay using the EV clone 
of CTLL-2 cells and CT4S cells, respectively, using 5000 cells/well and 
overnight PHFhymidine pulses in 48 hr assays. IFNy was measured by 
enzyme-linked immunosorbent assay. Wells were coated with antibod- 
ies lo IFNy (XMG cell line, PharMingen), and developed using a rabbit 
antiserum to IFNy (provided by C. Kinzer, National Institute of Allergy 
and Infectious Diseases), goat anti-rabbit horseradish peroxidase 
(Southern Biotechnical Associates) and H202 and PT peroxidase buffer 
(Kirkegaard and Perry Laboratories). Cytokine levels in control and 
ycmR mice were expressed as mean f SEM and values compared 
using the Student’s t test. 
For PH]thymidine incorporation studies in thymocytes, in some ex- 
periments, cells were cultured either at 2.5 x 1O’cells/well in a 96well 
flat-bottomed plate and stimulated with RPMI, PMA (10 nglml) plus 
IL-4 (1000 U/ml), or PMA plus ionomycin (1 pM). Alternatively, lo5 
cells/well were stimulated with plate-bound anti-CD3 plus soluble anti- 
CD28 as described above. Cells were pulsed with i5H]thymidine for 
the final 12 hr of a 48 hr assay. For 13H]thymidine incorporation studies 
in splenocytes, in some experiments either 5 x 10’ or 105 cells/well 
were stimulated with lipopolysaccharide (20 kg/ml) or IL-4 plus anti-p 
(5 @ml). Alternatively, 105cellslwell werestimulated with RPMI, PMA 
plus ionomycin, or anti-CD3 plus anti-CD28 antibodies, and pulsed 
with [3H]thymidine as described above. 
Mast Cell Assay 
Wells were coated with IgE (10 pglml) for 2 hr at 37OC in PBS, and 
2 x 105unfractionafedsplenocytes/welladded in 10% WEHl3Bcondi- 
tioned medium and IL-3 (100 rig/ml). IL4 (U/ml) was measured at 
24 hr. 
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